Active ingredient
Inotuzumab ozogamicin NDC Codes
Inotuzumab ozogamicin is an active ingredient in 1 finished product listed with the FDA, under 1 name.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Besponsa
- Strengths
- Inotuzumab ozogamicin .25 mg/mL
- Dosage forms
- Injection, Powder, Lyophilized, For solution
- Routes
- Intravenous
- Drug classes (FDA established)
- CD22-directed Immunoconjugate
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 1
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Besponsainotuzumab ozogamicin | Inotuzumab ozogamicin .25 mg/mL | Injection, Powder, Lyophilized, For solutionIntravenous | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 0008-0100 | 00008-0100-01 | — |
Inotuzumab ozogamicin: common questions
- Which drugs contain Inotuzumab ozogamicin?
- Besponsa.
- Is there a J-code for Inotuzumab ozogamicin?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.